AstraZeneca changes name of the vaccine

The company AstraZeneca changes the name of the coronavirus vaccine it produces and calls it Vaxzevria.

The company stressed that the drug is unchanged and the novelty is only about the name; the Swedish Medical Products Agency spreads the information.

According to a new study, the effectiveness of the AstraZeneca vaccine is 76% against symptomatic disease and 100% against severe disease.